BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38001975)

  • 1. Low Plasma Levels of Soluble Endoglin and Cardiovascular Events in Patients Undergoing Coronary Angiography.
    Saita E; Kishimoto Y; Aoyama M; Ohmori R; Kondo K; Momiyama Y
    Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38001975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Soluble Endoglin Levels Are Inversely Associated With the Severity of Coronary Atherosclerosis-Brief Report.
    Saita E; Miura K; Suzuki-Sugihara N; Miyata K; Ikemura N; Ohmori R; Ikegami Y; Kishimoto Y; Kondo K; Momiyama Y
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):49-52. PubMed ID: 27789477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High plasma levels of endosialin and cardiovascular events in patients undergoing coronary angiography.
    Kishimoto Y; Saita E; Ohmori R; Kondo K; Momiyama Y
    Heart Vessels; 2024 Jan; ():. PubMed ID: 38189922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between Plasma Interleukin-27 Levels and Cardiovascular Events in Patients Undergoing Coronary Angiography.
    Saita E; Kishimoto Y; Ohmori R; Kondo K; Momiyama Y
    J Cardiovasc Dev Dis; 2024 Apr; 11(5):. PubMed ID: 38786961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between high plasma levels of legumain and cardiovascular events in patients undergoing coronary angiography.
    Momiyama Y; Kishimoto Y; Saita E; Ohmori R; Kondo K
    Heart Vessels; 2024 Jan; ():. PubMed ID: 38289388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of plasma high-sensitivity C-reactive protein levels in Japanese patients with stable coronary artery disease: the Japan NCVC-Collaborative Inflammation Cohort (JNIC) Study.
    Momiyama Y; Kawaguchi A; Kajiwara I; Ohmori R; Okada K; Saito I; Konishi M; Nakamura M; Sato S; Kokubo Y; Mannami T; Adachi H; Kario K; Iso H; Ohsuzu F; Tsushima M
    Atherosclerosis; 2009 Nov; 207(1):272-6. PubMed ID: 19439303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma endoglin as a marker to predict cardiovascular events in patients with chronic coronary artery diseases.
    Ikemoto T; Hojo Y; Kondo H; Takahashi N; Hirose M; Nishimura Y; Katsuki T; Shimada K; Kario K
    Heart Vessels; 2012 Jul; 27(4):344-51. PubMed ID: 21667051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease.
    Wu TC; Leu HB; Lin WT; Lin CP; Lin SJ; Chen JW
    Eur J Clin Invest; 2005 Sep; 35(9):537-45. PubMed ID: 16128859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor long-term outcomes in stroke patients with asymptomatic coronary artery disease in heart CT.
    Yoo J; Song D; Baek JH; Kim K; Kim J; Song TJ; Lee HS; Choi D; Kim YD; Nam HS; Heo JH
    Atherosclerosis; 2017 Oct; 265():7-13. PubMed ID: 28825975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsia.
    Rana S; Cerdeira AS; Wenger J; Salahuddin S; Lim KH; Ralston SJ; Thadhani RI; Karumanchi SA
    PLoS One; 2012; 7(10):e48259. PubMed ID: 23110221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble endoglin and transforming growth factor-β₁ and the development of vasospasm after spontaneous subarachnoid hemorrhage: a pilot study.
    Dietmann A; Lackner P; Fischer M; Broessner G; Pfausler B; Helbok R; Schmutzhard E; Beer R
    Cerebrovasc Dis; 2012; 33(1):16-22. PubMed ID: 22133666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients With Stable Coronary Artery Disease.
    Hsu CY; Tseng WK; Wu YW; Lin TH; Yeh HI; Chang KC; Wang JH; Chou RH; Huang CY; Huang PH; Leu HB; Yin WH; Wu CC; Lin SJ; Chen JW
    Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):1240-1252. PubMed ID: 30943772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum resistin levels and cardiovascular events in patients undergoing percutaneous coronary intervention.
    Momiyama Y; Ohmori R; Uto-Kondo H; Tanaka N; Kato R; Taniguchi H; Arakawa K; Nakamura H; Ohsuzu F
    J Atheroscler Thromb; 2011; 18(2):108-14. PubMed ID: 21071880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High soluble endoglin levels do not induce changes in structural parameters of mouse heart.
    Rathouska J; Fikrova P; Mrkvicova A; Blazickova K; Varejckova M; Dolezelova E; Nemeckova I; Vitverova B; Peslova L; Gallardo-Vara E; Pericacho M; Nachtigal P
    Heart Vessels; 2017 Aug; 32(8):1013-1024. PubMed ID: 28382387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SuPAR is associated with death and adverse cardiovascular outcomes in patients with suspected coronary artery disease.
    Hodges G; Lyngbæk S; Selmer C; Ahlehoff O; Theilade S; Sehestedt TB; Abildgaard U; Eugen-Olsen J; Galløe AM; Hansen PR; Jeppesen JL; Bang CN
    Scand Cardiovasc J; 2020 Dec; 54(6):339-345. PubMed ID: 32400206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma C20-Sphingolipids predict cardiovascular events independently from conventional cardiovascular risk factors in patients undergoing coronary angiography.
    Othman A; Saely CH; Muendlein A; Vonbank A; Drexel H; von Eckardstein A; Hornemann T
    Atherosclerosis; 2015 May; 240(1):216-21. PubMed ID: 25801014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble endoglin modulates the pro-inflammatory mediators NF-κB and IL-6 in cultured human endothelial cells.
    Varejckova M; Gallardo-Vara E; Vicen M; Vitverova B; Fikrova P; Dolezelova E; Rathouska J; Prasnicka A; Blazickova K; Micuda S; Bernabeu C; Nemeckova I; Nachtigal P
    Life Sci; 2017 Apr; 175():52-60. PubMed ID: 28336397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An elevated ratio of placental growth factor to soluble fms-like tyrosine kinase-1 predicts adverse outcomes in patients with stable coronary artery disease.
    Matsumoto T; Uemura S; Takeda Y; Matsui M; Okada S; Nishida T; Soeda T; Okayama S; Somekawa S; Ishigami K; Onoue K; Kawata H; Kawakami R; Horii M; Saito Y
    Intern Med; 2013; 52(10):1019-27. PubMed ID: 23676585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Role of Circulating Endoglin in Hypertension via the Upregulated Expression of BMP4.
    Gallardo-Vara E; Gamella-Pozuelo L; Perez-Roque L; Bartha JL; Garcia-Palmero I; Casal JI; López-Novoa JM; Pericacho M; Bernabeu C
    Cells; 2020 Apr; 9(4):. PubMed ID: 32316263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women.
    Wessel TR; Arant CB; Olson MB; Johnson BD; Reis SE; Sharaf BL; Shaw LJ; Handberg E; Sopko G; Kelsey SF; Pepine CJ; Merz NB
    JAMA; 2004 Sep; 292(10):1179-87. PubMed ID: 15353530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.